SCHEMBL24908341

SCHEMBL24908341

Bc1c(B)c(B)c2c(-c3cccc4c3C(C)(C)c3ccccc3-4)c3c(B)c(B)c(B)c(B)c3c(-c3ccc4oc5c6ccccc6ccc5c4c3)c2c1B

nearest known ligand 0.31

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.31
CDC25A P30304 1/20 0.31
CDC25C P30307 1/20 0.31
ALOX5 P09917 1/20 0.31
KMT2A Q03164 2/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
MEN1 O00255 1/20 0.31
ESR1 P03372 1/20 0.31
POLB P06746 1/20 0.31
CYP1A1 P04798 2/20 0.30
CYP1B1 Q16678 2/20 0.30
MAOB P27338 1/20 0.30
CYP1A2 P05177 1/20 0.30
ABCB1 P08183 1/20 0.30
ABCC1 P33527 1/20 0.30
ABCG2 Q9UNQ0 1/20 0.30
HPGD P15428 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24908431 0.95 ARSA (0.30) ARSACDC25ACDC25CALOX5KMT2A
SCHEMBL25035692 0.94 ALOX5 (0.32) ARSACDC25ACDC25CALOX5KDM4E
SCHEMBL25035773 0.90 ARSA (0.34) ARSACDC25ACDC25CKMT2AKDM4E
SCHEMBL25035905 0.90 PRKDC (0.32) ARSACDC25ACDC25CKMT2AKDM4E
SCHEMBL24908321 0.89 KDM4E (0.31) ARSACDC25ACDC25CKDM4EALDH1A1
SCHEMBL24908350 0.89 ARSA (0.32) ARSACDC25ACDC25CKDM4EALDH1A1
SCHEMBL24908433 0.88 ARSA (0.30) ARSACDC25ACDC25CALOX5KMT2A
SCHEMBL24908189 0.88 PRKDC (0.31) ARSACDC25ACDC25CKMT2AKDM4E
SCHEMBL24908338 0.88 PRKDC (0.31) ARSACDC25ACDC25CKMT2AKDM4E
SCHEMBL24908436 0.88 ARSA (0.32) ARSACDC25ACDC25CKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230042023-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-09 US disclosed
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS MRPS22, RER1, EMC2 ARSA 2350/4885CDC25A 4007/4885CDC25C 4287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.